Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trialsArticle Published on 2022-11-012022-11-15 Journal: European Journal of Clinical Pharmacology [Category] [DOI] 10.1007/s00228-022-03380-5 PMC 바로가기
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosisArticle Published on 2022-11-012022-11-16 Journal: Journal of hepatology [Category] [DOI] 10.1016/j.jhep.2022.07.036 PMC 바로가기
Notes From the Field: Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability – United States, December 23, 2021-August 28, 2022Article Published on 2022-10-282022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] [DOI] 10.15585/mmwr.mm7143a3 PMC 바로가기
Severity predictors of COVID-19 in SARS-CoV-2 variant, delta and omicron period; single center studyArticle Published on 2022-10-252022-11-16 Journal: PLoS ONE [Category] [DOI] 10.1371/journal.pone.0273134 PMC 바로가기
The role of exhaled nitric oxide (FeNO) in the evaluation of lung parenchymal involvement in COVID-19 patientsArticle Published on 2022-10-012022-11-16 Journal: Internal and Emergency Medicine [Category] [DOI] 10.1007/s11739-022-03035-4 PMC 바로가기
The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID studyObservational Study Published on 2022-10-012022-10-05 Journal: Journal of cardiology [Category] [DOI] 10.1016/j.jjcc.2022.03.015 PMC 바로가기 [Article Type] Observational Study
Association of mental health with clinical outcomes in hospitalized patients with moderate COVID-19Research article Published on 2022-09-012022-10-05 Journal: Journal of affective disorders [Category] [DOI] 10.1016/j.jad.2022.05.047 [Article Type] Research article
[Building COVID-19’s semiology: The blind wise men and the elephant]Article Published on 2022-09-012022-11-16 Journal: Gaceta sanitaria [Category] [DOI] 10.1016/j.gaceta.2021.12.004 PMC 바로가기
Successful recruitment of monolingual Spanish speaking Latinos to university phase II and III outpatient COVID-19 clinical treatment trials in Northern CaliforniaClinical Trial Published on 2022-09-012022-10-05 Journal: Contemporary clinical trials [Category] [DOI] 10.1016/j.cct.2022.106891 [Article Type] Clinical Trial
Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019Article Published on 2022-09-012022-11-15 Journal: Mayo Clinic proceedings [Category] [DOI] 10.1016/j.mayocp.2022.06.015 PMC 바로가기